MedTrace Logo

Coronaphobia in Rheumatic Diseases

NCT05554029 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-26

No results posted yet for this study

Summary

COVID-19 is a contagious respiratory disease that is caused Severe Acute Respiratory Syndrome causing Coronavirus-2 (SARS-CoV-2). The most common symptoms are fever, cough and dyspnoea. Patients with rheumatic diseases are at higher risk of infections because of disease activity and immunosuppression. In addition, old age and having concomitant chronic disease are among risk factors for coronavirus. Therefore, national health services recommend patients to practice self-isolation and self-quarantine.

Conditions

  • Rheumatic Diseases

Interventions

DIAGNOSTIC_TEST

Coronaphobia

Coronophobia will be assessed with COVID-19-phobia scale.

Sponsors & Collaborators

  • Firat University

    collaborator OTHER

  • Gazi University

    lead OTHER

Principal Investigators

  • Songul B Yentur · Gazi University

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-25
Primary Completion
2022-11-20
Completion
2022-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05554029 on ClinicalTrials.gov